{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:46:10Z","timestamp":1761709570871,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.purol.2018.11.001","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T01:23:23Z","timestamp":1546737803000},"page":"216-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Int\u00e9r\u00eat de la toxine botulinique A dans le traitement des troubles pelvi-p\u00e9rin\u00e9aux de la personne \u00e2g\u00e9e"],"prefix":"10.1016","volume":"29","author":[{"given":"X.","family":"Biardeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chesnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Charlanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Turmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Campagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Capon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Fatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jeandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kerdraon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mezzadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-C.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thuillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Deffieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Manceau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2018.11.001_bib0325","unstructured":"Insee, estimations de population. \u00c9volution de la structure de la population, France 2018."},{"key":"10.1016\/j.purol.2018.11.001_bib0330","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/nau.22295","article-title":"The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial\/ethnic group and age: results from OAB-POLL","volume":"32","author":"Coyne","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2018.11.001_bib0335","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/nau.23446","article-title":"The prevalence of lower urinary tract symptoms (LUTS) in Brazil: results from the epidemiology of LUTS (Brazil LUTS) study","volume":"37","author":"Soler","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2018.11.001_bib0340","first-page":"919","article-title":"Epidemiology and management of chronic constipation in elderly patients","volume":"10","author":"Vazquez Roque","year":"2015","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.purol.2018.11.001_bib0345","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00192-017-3365-9","article-title":"Female double incontinence: prevalence, incidence, and risk factors from the SABE (Health, Wellbeing and Aging) study","volume":"29","author":"Yuaso","year":"2018","journal-title":"Int Urogynecology J"},{"key":"10.1016\/j.purol.2018.11.001_bib0350","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.archger.2016.11.006","article-title":"Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis","volume":"69","author":"Vouri","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.purol.2018.11.001_bib0355","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.eururo.2010.11.021","article-title":"EAU guidelines on urinary incontinence","volume":"59","author":"Th\u00fcroff","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.purol.2013.11.016","article-title":"[Guidelines concerning urinary incontinence in elderly: construction and validation of GRAPPPA algorithm]","volume":"24","author":"Amarenco","year":"2014","journal-title":"Progres En Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0365","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.purol.2015.01.006","article-title":"[Idiopathic overactive bladder and BOTOX(\u00ae): Literature review]","volume":"25","author":"Gam\u00e9","year":"2015","journal-title":"Progres En Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100\u00a0U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0375","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0380","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.juro.2008.08.030","article-title":"Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population","volume":"180","author":"White","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0385","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2012.11.089","article-title":"Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity","volume":"189","author":"Liao","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0390","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00192-016-3212-4","article-title":"Urinary retention in female OAB after intravesical Botox injection: who is really at risk\u00a0?","volume":"28","author":"Miotla","year":"2017","journal-title":"Int Urogynecology J"},{"key":"10.1016\/j.purol.2018.11.001_bib0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5213\/inj.1835008.504","article-title":"Intermittent self-catheterization in older adults: predictors of success for technique learning","volume":"22","author":"Hentzen","year":"2018","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.purol.2018.11.001_bib0400","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.juro.2009.06.023","article-title":"Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy","volume":"182","author":"Giannantoni","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0405","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.purol.2018.11.001_bib0410","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0415","doi-asserted-by":"crossref","first-page":"e105989","DOI":"10.1371\/journal.pone.0105989","article-title":"Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder","volume":"9","author":"Jiang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.purol.2018.11.001_bib0420","first-page":"S122","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"McVary","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.purol.2018.11.001_bib0425","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7258(02)00174-2","article-title":"Cholinergic innervation and function in the prostate gland","volume":"94","author":"Ventura","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.purol.2018.11.001_bib0430","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0435","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","article-title":"Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates","volume":"65","author":"Kuo","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0440","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1464-410X.2006.06479.x","article-title":"Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia","volume":"98","author":"Chuang","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2018.11.001_bib0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-6-12","article-title":"Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs","volume":"6","author":"Chuang","year":"2006","journal-title":"BMC Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0450","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3349\/ymj.2006.47.5.706","article-title":"Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia","volume":"47","author":"Park","year":"2006","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.purol.2018.11.001_bib0455","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eururo.2007.08.050","article-title":"Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption","volume":"53","author":"Silva","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0460","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2008.08.475","article-title":"Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results","volume":"73","author":"Brisinda","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0465","doi-asserted-by":"crossref","first-page":"463574","DOI":"10.1100\/2012\/463574","article-title":"Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses","volume":"2012","author":"Arnouk","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.purol.2018.11.001_bib0470","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00345-012-0851-z","article-title":"Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates","volume":"31","author":"Hamidi Madani","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0475","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.urology.2012.06.004","article-title":"Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia","volume":"80","author":"de Kort","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0480","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.eururo.2012.10.005","article-title":"A randomized double-blind placebo-controlled phase 2\u00a0dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia","volume":"63","author":"Marberger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11255-015-1153-3","article-title":"Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"48","author":"Shim","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2018.11.001_bib0490","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2007.03.002","article-title":"Effects of botulinum toxin A on the contractile function of dog prostate","volume":"52","author":"Lin","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0495","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0500","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24\u00a0spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0505","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum-A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.purol.2018.11.001_bib0510","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","article-title":"Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13\u00a0patients with spinal cord disease","volume":"42","author":"de S\u00e8ze","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0515","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.urology.2008.04.026","article-title":"Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection","volume":"72","author":"Kuo","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0520","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2340\/16501977-0255","article-title":"Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury","volume":"40","author":"Chen","year":"2008","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.purol.2018.11.001_bib0525","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.apmr.2008.10.023","article-title":"Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance","volume":"90","author":"Tsai","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.purol.2018.11.001_bib0530","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.apmr.2009.11.006","article-title":"Transrectal ultrasound-guided transperineal botulinum toxin a injection to the external urethral sphincter for treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury","volume":"91","author":"Chen","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.purol.2018.11.001_bib0535","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.purol.2018.11.001_bib0540","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1464-410X.1992.tb15793.x","article-title":"Botulinum toxin in the treatment of chronic urinary retention in women","volume":"70","author":"Fowler","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0545","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110\u00a0patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0550","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000087803","article-title":"Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy","volume":"75","author":"Kuo","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2018.11.001_bib0555","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.urology.2007.06.1083","article-title":"Causes of failed urethral botulinum toxin A treatment for emptying failure","volume":"70","author":"Liao","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0560","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/00016348009154090","article-title":"Urethral pressure profile in continent women from childhood to old age","volume":"59","author":"Rud","year":"1980","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.purol.2018.11.001_bib0565","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0022-5347(01)65496-X","article-title":"Urethral closure pressure changes with age in men","volume":"156","author":"Hammerer","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0570","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0090-4295(02)02541-4","article-title":"Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity","volume":"61","author":"Kuo","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.11.001_bib0575","doi-asserted-by":"crossref","first-page":"38905","DOI":"10.1038\/srep38905","article-title":"OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction \u2013 A Randomized, Double-Blind, Placebo-Controlled Study","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.purol.2018.11.001_bib0580","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.purol.2018.04.001","article-title":"[Efficacy of botulinum toxin A injections in the urethral sphincter in patients with difficulties to perform self-intermittent catherization]","volume":"28","author":"Honore","year":"2018","journal-title":"Progres En Urol"},{"key":"10.1016\/j.purol.2018.11.001_bib0585","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10350-004-0593-0","article-title":"The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature","volume":"47","author":"Macmillan","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.purol.2018.11.001_bib0590","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1463-1318.2011.02585.x","article-title":"toxin as a treatment for overactive rectum with associated faecal incontinence","volume":"14","author":"Bridoux","year":"2012","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.purol.2018.11.001_bib0595","first-page":"484","article-title":"Botulinum toxin: an endoscopic approach for treating fecal incontinence","volume":"48","author":"Gourcerol","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.purol.2018.11.001_bib0600","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10350-005-0249-8","article-title":"Defecation disorders: a French population survey","volume":"49","author":"Siproudhis","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.purol.2018.11.001_bib0605","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/BF02081409","article-title":"Initial North American experience with botulinum toxin type A for treatment of anismus","volume":"39","author":"Joo","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.purol.2018.11.001_bib0610","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0022-3468(97)90399-7","article-title":"Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease","volume":"32","author":"Langer","year":"1997","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.purol.2018.11.001_bib0615","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1111\/j.1572-0241.2006.00791.x","article-title":"Experience with type A botulinum toxin for treatment of outlet-type constipation","volume":"101","author":"Maria","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.purol.2018.11.001_bib0620","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jpedsurg.2006.12.045","article-title":"Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blind randomized trial","volume":"42","author":"Keshtgar","year":"2007","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.purol.2018.11.001_bib0625","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00383-008-2171-3","article-title":"Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction","volume":"24","author":"Irani","year":"2008","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.purol.2018.11.001_bib0630","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2036.2005.02669.x","article-title":"Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment","volume":"22","author":"Cadeddu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.purol.2018.11.001_bib0635","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpedsurg.2017.12.007","article-title":"Botulinum toxin injection for childhood constipation is safe and can be effective regardless of anal sphincter dynamics","volume":"53","author":"Zar-Kessler","year":"2018","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.purol.2018.11.001_bib0320","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002512-200421140-00002","article-title":"The treatment of chronic constipation in elderly people: an update","volume":"21","author":"Bosshard","year":"2004","journal-title":"Drugs Aging"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718306389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718306389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:31:30Z","timestamp":1761114690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708718306389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1166708718306389"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2018.11.001","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat de la toxine botulinique A dans le traitement des troubles pelvi-p\u00e9rin\u00e9aux de la personne \u00e2g\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}